4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid
C22H19F7N2O3 — CID 87626821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid
4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid (PubChem CID 87626821) has the molecular formula C22H19F7N2O3 and a molecular weight of 492.39 g/mol. Its IUPAC name is 4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid.
Molecular Properties
| Compound Name | 4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid |
|---|---|
| PubChem CID | 87626821 |
| Molecular Formula | C22H19F7N2O3 |
| Molecular Weight | 492.39 g/mol |
| Exact Mass | 492.13 |
| IUPAC Name | 4-[[3,5-bis(trifluoromethyl)benzoyl]amino]-3-(4-fluoro-3-methylphenyl)piperidine-1-carboxylic acid |
| SMILES | Cc1cc(C2CN(C(=O)O)CCC2NC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccc1F |
| InChI | InChI=1S/C22H19F7N2O3/c1-11-6-12(2-3-17(11)23)16-10-31(20(33)34)5-4-18(16)30-19(32)13-7-14(21(24,25)26)9-15(8-13)22(27,28)29/h2-3,6-9,16,18H,4-5,10H2,1H3,(H,30,32)(H,33,34) |
| InChIKey | FHIYMRZRBZXMDA-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 69.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.39 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87626821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.